Invesco U.S. Small Cap Enhanced ETF (IQES) is an Invesco ETF with a 0.26% expense ratio, 1,186 holdings and $6.2MM in net assets. Largest sector: Healthcare (20%).
Fee
0.26%
expense ratio
Net assets
$6.2MM
Launched
Nov 11, 2026
Holdings
1,186
as of Nov 12, 2026
Top 10 weight
3.5%
largest ten holdings
Largest sector
Healthcare
20.3%
Yield
—
Benchmark
—
IQES's holdings are as of Nov 12, 2026.
Of its stocks, 98% are US and 2% international. A stock counts under its company’s home country, wherever it is listed.
Healthcare
20.3%
Financial Services
19.1%
Technology
14.5%
Industrials
12.9%
Consumer Cyclical
10.7%
Energy
6.1%
Real Estate
5.9%
Basic Materials
3.7%
Utilities
2.4%
Consumer Defensive
2.2%
Communication Services
2.1%
Banks—Regional
11.7%
Biotechnology
9.6%
Software—Application
4.0%
Software—Infrastructure
3.2%
Medical Devices
2.4%
Drug Manufacturers—Specialty & Generic
2.3%
Medical Care Facilities
1.9%
Capital Markets
1.8%
Specialty Chemicals
1.8%
Oil & Gas E&P
1.6%
The 10 largest of 29 industries (each at least 1%). Industries come from market-data classification and can differ from the fund issuer's own categories.
1
GKOS
Glaukos
0.47%
2
FROG
JFrog Ltd.
0.40%
3
BTSG
BrightSpring Health Services
0.40%
4
ZION
Zions Bancorp NA
0.34%
5
PTGX
Protagonist Therapeutics
0.34%
6
JXN
JACKSON FINANCIAL
0.33%
7
VSAT
Viasat
0.33%
8
UMBF
UMB Financial
0.32%
9
EAT
Brinker International
0.32%
10
TGTX
TG Therapeutics
0.30%
11
MOG.A
MOOG INC-CLASS A
0.30%
12
RHP
Ryman Hospitality Properties
0.29%
13
ZETA
Zeta Global Holdings Class A
0.29%
14
PCVX
Vaxcyte
0.28%
15
VSXY
Victoria's Secret
0.28%
16
TWST
TWIST BIOSCIENCE
0.28%
17
HQY
HealthEquity
0.28%
18
CMC
Commercial Metals
0.28%
19
PBF
PBF Energy Class A
0.28%
20
OSCR
Oscar Health Class A
0.27%
21
KRYS
Krystal Biotech
0.26%
22
TXG
10X GENOMICS INC-CLASS A
0.26%
23
SYRE
Spyre Therapeutics
0.26%
24
ANF
Abercrombie & Fitch
0.25%
25
PRAX
Praxis Precision Medicines
0.25%
1–25 of 1,186